A patent review of anticancer CDK2 inhibitors (2017 –present)

.

Source: Expert Opinion on Therapeutic Patents - May 26, 2022 Category: Drugs & Pharmacology Authors: Mohamed A. Said Mohamed A. Abdelrahman Mohammed A.S. Abourehab Mohamed Fares Wagdy M. Eldehna Source Type: research